CompanyTARANasdaqNew York, NY

Protara Therapeutics

Protara develops cell-based and phospholipid therapies for cancer and rare diseases.

SEC EDGAR ClinicalTrials.gov protaratx.com

8-KSep 22Latest SEC filing, period to Sep 18

Sep 22Latest story

August 2026

Protara reports Q2 2026 results, redesigns ADVANCED-3 trial for TARA-002

Aug 11Quarterly updateProtara Therapeutics TARA-002

June 2026

Protara Therapeutics' chief medical officer resigns effective June 26, 2026

Jun 29PeopleProtara Therapeutics